Accessibility Menu
Viveve Medical logo

Viveve Medical

(OTC) VIVE

Current Price$0.00
Market Cap$2,100
Since IPO (1992)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Viveve Medical Financials at a Glance

Market Cap

$2,100

Revenue (TTM)

$6.83M

Net Income (TTM)

$23.92M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-78.95 (Low)

Price

$0.00

Volume

125

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

VIVE News

No articles available.

VIVE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Viveve Medical

Industry

Healthcare Equipment and Supplies

Employees

47

CEO

Scott C. Durbin

Headquarters

Englewood, CO 80112, US

VIVE Financials

Key Financial Metrics (TTM)

Gross Margin

10%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-85%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.10K

Shares Outstanding

10.72M

Volume

125

Short Interest

0.00%

Avg. Volume

1.81K

Financials (TTM)

Gross Profit

$620.00K

Operating Income

$21.55M

EBITDA

$19.63M

Operating Cash Flow

$12.88M

Capital Expenditure

$456.00K

Free Cash Flow

$13.33M

Cash & ST Invst.

$19.16M

Total Debt

$5.35M

Viveve Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$1.68M

+4.2%

Gross Profit

$546.00K

+378.9%

Gross Margin

32.42%

N/A

Market Cap

$2.10K

N/A

Market Cap/Employee

$44.68

N/A

Employees

47

N/A

Net Income

$5.29M

+9.7%

EBITDA

$4.51M

+15.3%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Net Cash

$26.00K

-99.9%

Accounts Receivable

$860.00K

+67.3%

Inventory

$1.61M

-24.9%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$5.88M

+2648.1%

Return on Assets

-85.00%

N/A

Return on Invested Capital

-1.01%

N/A

Free Cash Flow

$3.54M

-29.0%

Operating Cash Flow

$3.35M

-25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
STBVStrategic Global Investments, Inc.
$0.00+0.00%
BXRXQBaudax Bio, Inc.
$0.00+0.00%
TNGNQTengion, Inc.
$0.00+0.00%
NMRDNemaura Medical Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.54-0.03%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$86.05-0.02%
PLPlanet Labs PBC
$33.91+0.26%

Questions About VIVE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.